Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review
An. bras. dermatol; 95 (1), 2020
Abstract Topical use of immune response modifiers, such as imiquimod, has increased in dermatology. Although its topical use is well tolerated, it may be associated with exacerbations of generalized cutaneous inflammatory diseases, possibly through the systemic circulation of pro-inflammatory cytokines. ...
Corticoesteroides/uso terapéutico, Antineoplásicos/efectos adversos, Biopsia, Fármacos Dermatológicos/uso terapéutico, Imiquimod/efectos adversos, Queratosis Actínica/tratamiento farmacológico, Metotrexato/uso terapéutico, Persona de Mediana Edad, Pitiriasis Rubra Pilaris/inducido químicamente, Pitiriasis Rubra Pilaris/tratamiento farmacológico, Pitiriasis Rubra Pilaris/patología, Resultado del Tratamiento